Citation Impact
Citing Papers
The Clinical Spectrum of Aspergillosis—Part 1: Epidemiology, Pathogenicity, Infection in Animals and Immunology of Aspergillus
1980
The Clinical Spectrum of Aspergillosis–Part 2: Classification and Description of Saprophytic, Allergic, and Invasive Variants of Human Disease
1980
Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils.
1992
Exposure to an Aeroallergen as a Possible Precipitating Factor in Respiratory Arrest in Young Patients with Asthma
1991 Standout
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
2008 Standout
Atopic dermatitis
2003 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
IgE antibody up-regulates high affinity IgE binding on murine bone marrow-derived mast cells
1996
Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management
1990
Experimental Allergic Bronchopulmonary Aspergillosis in the Mouse: Immunological and Histological Features
1994
Aspergillus fumigatus: Identification of 16, 18, and 45 kd antigens recognized by human IgG and IgE antibodies and murine monoclonal antibodies
1992
Allergic bronchopulmonary aspergillosis
2002
Atopic dermatitis
2015 Standout
Effectiveness of voriconazole in the treatment of Aspergillus fumigatus–associated asthma (EVITA3 study)
2013
Characterization of a primate model of asthma using anti-allergy/ anti-asthma agents
1996
Specific serum immunopatterns in clinical phases of allergic bronchopulmonary aspergillosis
1992
Heparin-induced thrombocytopenia with thrombosis: Incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution
1997
Heparin-Induced Thrombocytopenia
1998
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
2009 Standout
IgE and mast cells in allergic disease
2012 Standout
Guidelines for the management of work-related asthma
2012
Immune responses to Aspergillus in cystic fibrosis
1988
Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis—State of the Art: Cystic Fibrosis Foundation Consensus Conference
2003
Temporal Aspects of Heparin-Induced Thrombocytopenia
2001 Standout
Specific Granules of Human Eosinophils Have Lysosomal Characteristics: Presence of Lysosome-Associated Membrane Proteins and Acidification upon Cellular Activation
2002
Detection of immunoglobulins G and A to Aspergillus fumigatus by immunoblot analysis for monitoring Aspergillus-induced lung diseases
1998
Mast Cells in Fibrotic Lung Disorders
1993
Asthma
2017 Standout
The biology and pharmacology of PGD2
1988
Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine
2004 Standout
Pulmonary immune cells in health and disease: the eosinophil leucocyte (Part I)
1994
Is the Placebo Powerless?
2001
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Heparin-Induced Thrombocytopenia
2006 Standout
Asp f I CD4 + TH2-like T-cell lines in allergic bronchopulmonary aspergillosis
1994
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
2012 Standout
An Antibody Fragment from a Phage Display Library Competes for Ligand Binding to the Low Density Lipoprotein Receptor Family and Inhibits Rhinovirus Infection
1995 StandoutNobel
Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression
1996 StandoutNobel
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
1995 Standout
Immunoblot analysis of sera from patients with allergic bronchopulmonary aspergillosis: Correlation with disease activity
1990
Sarcoidosis
1997 Standout
Serum anti-Aspergillus fumigatus antibodies by immunoblot and ELISA in cystic fibrosis with allergic bronchopulmonary aspergillosis
1994
Heparin‐induced thrombocytopenia: mechanism of interaction of the heparin‐dependent antibody with platelets
1989
Allergic Bronchopulmonary Aspergillosis in Patients with Cystic Fibrosis
1990
Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children.
1988
The Pathophysiology of Heparin-Induced Thrombocytopenia
2005
A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
1995 Standout
Prolonged evaluation of patients with corticosteroid-dependent asthma stage of allergic bronchopulmonary aspergillosis
1987
Placebo interventions for all clinical conditions
2004
A Randomized Trial of Itraconazole in Allergic Bronchopulmonary Aspergillosis
2000
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens.
1993
A critical review of low-level prenatal lead exposure in the human: 2. Effects on the developing child
1992
A Controlled Trial of Arthroscopic Surgery for Osteoarthritis of the Knee
2002 Standout
Molecular cloning and expression of a recombinant Aspergillus fumigatus protein Asp f II with significant immunoglobulin E reactivity in allergic bronchopulmonary aspergillosis
1996
Recombinant Aspergillus fumigatus Allergens: From the Nucleotide Sequences to Clinical Applications
1998
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Practice Guidelines for Diseases Caused by Aspergillus
2000
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Late Asthmatic Responses
1987
American Thoracic Society Statement
2003 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Head and neck aspergillosis in patients undergoing bone marrow transplantation. Report of four cases and review of the literature
1986 StandoutNobel
Leukocyte histamine release in Hymenoptera-allergic patients
1973
Allergic bronchopulmonary aspergillosis in cystic fibrosis
1984
Coated pits, coated vesicles, and receptor-mediated endocytosis
1979 StandoutNatureNobel
Immunological Studies with Synthetic Polypeptides
1966
Current Trends in Immunodiagnosis of Candidiasis and Aspergillosis
1984
Oxatomide, a new orally active drug which inhibits both the release and the effects of allergic mediators
1977
Platelet-activating factor.
1990 Standout
Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
1994
PHYLOGENETIC ORIGINS OF ANTIBODY STRUCTURE
1965 StandoutNobel
Fc epsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation.
1998
The Clinical Usefulness of the Platelet Aggregation Test for the Diagnosis of Heparin-Induced Thrombocytopenia
1993
Heparin-lnduced Thrombocytopenia, Thrombosis, and Hemorrhage
1983
Fcε Receptor I on Dendritic Cells Delivers IgE-Bound Multivalent Antigens into a Cathepsin S-Dependent Pathway of MHC Class II Presentation
1998
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Allergic Bronchopulmonary Aspergillosis
1987
Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency
2011
Antibodies Reactive with Native Lysozyme Elicited by a Completely Synthetic Antigen
1971 StandoutNobel
Asymmetric Catalysis by Architectural and Functional Molecular Engineering: Practical Chemo- and Stereoselective Hydrogenation of Ketones
2001 StandoutNobel
British Guideline on the Management of Asthma
2008
Serodiagnosis of Aspergillosis
1991
Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2
1997 StandoutNobel
Asp f I CD4 + TH2-like T-cell lines in allergic bronchopulmonary aspergillosis
1994
Managing Cough as a Defense Mechanism and as a Symptom
1998
Effect of Heparin and Heparin Fractions on Platelet Aggregation
1980
Heparin-Associated Thrombocytopenia
1980
Endocytosis and the recycling of plasma membrane.
1983 StandoutNobel
Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophils
1997 StandoutNobel
Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4
1994
Different platelet specificities of heparin‐dependent platelet aggregating factors in heparin‐associated immune thrombocytopenia
1986
Risk factors for sensitisation and respiratory symptoms among workers exposed to acid anhydrides: a cohort study.
1998
Placebo interventions for all clinical conditions
2010
Studies on amphibian yolk
1969
IMMUNOLOGIC COMPETENCE OF THORACIC DUCT CELLS
1966
A STUDY OF THE PASSIVE TRANSFER OF DELAYED HYPERSENSITIVITY TO DNP-POLY-L -LYSINE AND DNP-GL IN RESPONDER AND NONRESPONDER GUINEA PIGS
1967 StandoutNobel
Ontogeny and Phylogeny of Adaptive Immunity
1964
Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
1991
Role of the coated endocytic vesicle in the uptake of receptor-bound low density lipoprotein in human fibroblasts
1977 StandoutNobel
Aspergillus fumigatusand Aspergillosis
1999 Standout
Allergic Aspergillus sinusitis: a newly recognized form of sinusitis
1983
Protein transport: A selective membrane mechanism
1976
A mutation that impairs the ability of lipoprotein receptors to localise in coated pits on the cell surface of human fibroblasts
1977 StandoutNatureNobel
Immunobiology of Dendritic Cells
2000 Standout
SPECIFIC IMMUNE RESPONSE GENES OF THE GUINEA PIG
1971 StandoutNobel
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Determinants of antigenic molecules responsible for genetically controlled regulation of immune responses.
1976 StandoutNobel
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Low-Molecular-Weight Heparins
1997 Standout
Isolation and characterization of a hemagglutinin from Limulus polyphemus
1968 StandoutNobel
Aspergillus fumigatus allergen I, a major IgE-binding protein, is a member of the mitogillin family of cytotoxins.
1990
Grain fever syndrome induced by inhalation of airborne grain dust
1982
A Controlled Trial of Immunotherapy in Insect Hypersensitivity
1978 Standout
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface
2002 StandoutNobel
The diagnosis and management of anaphylaxis: An updated practice parameter
2005
Heparin-Associated Thrombocytopenia
1984
Stimulation of the Synthesis of Very Low Density Lipoproteins in Rooster Liver by Estradiol
1974 StandoutNobel
Antibodies to Macromolecular Platelet Factor 4-Heparin Complexes in Heparin-induced Thrombocytopenia: a Study of 44 Cases
1995
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia
2001 Standout
Immunodiagnosis of aspergillosis
1991
Immune Endothelial-Cell Injury in Heparin-Associated Thrombocytopenia
1987
Allergic Bronchopulmonary Aspergillosis: Staging as an Aid to Management
1982
Binding to specific receptors on oocyte plasma membranes by serum phosvitin‐lipovitellin
1976
Solubilization and characterization of the chicken oocyte vitellogenin receptor
1988
Works of R Patterson being referenced
Specific serum antibodies against isocyanates: Association with occupational asthma
1989
Prednisonephobia
1989
Allergic bronchopulmonary aspergillosis. Model of bronchopulmonary disease with defined serologic, radiologic, pathologic and clinical findings from asthma to fatal destructive lung disease
1987
HLA antigen frequencies in allergic bronchopulmonary aspergillosis
1978
Respiratory mast cells and basophiloid cells. I. Evidence that they are secreted into the bronchial lumen, morphology, degranulation and histamine release.
1974
Histamine in Human Leucocytes
1970
Effect of prostaglandin D2 and I2 on the airways of rhesus monkeys
1980
IgA antibody against Aspergillus fumigatus antigen in patients with allergic bronchopulmonary aspergillosis.
1980
Asthma as a variable in a study of immunotherapy for allergic rhinitis
1984
Living histamine-containing cells from the bronchial lumens of humans. Description and comparison of histamine content with cells of rhesus monkeys.
1977
Clinical and immunologic studies of ragweed immunotherapy
1971
Airway responses to sequential challenges with platelet-activating factor and leukotriene D4 in rhesus monkeys.
1984
Diagnosis and management of allergic bronchopulmonary aspergillosis.
1986
Elimination of Circulating Serum Protein Antigens as a Sensitive Measure of Antibody.
1960
The Metabolism of Serum Proteins in the Hen and Chick and Secretion of Serum Proteins by the Ovary of the Hen
1962
Prenatal lead exposure and its potential significance for developmental disabilities: a preliminary study of umbilical cord blood lead levels.
1988
Outcome of cough variant asthma treated with inhaled steroids.
1994
Four-year evaluation of workers exposed to trimellitic anhydride. A brief report.
1984
Dissociation of IgE from receptors on human basophils. I. Enhanced passive sensitization for histamine release.
1983
Cough variant asthma: Usefulness of a diagnostic therapeutic trial with prednisone
1994
Heparin immune thrombocytopenia: evidence for a heparin-platelet complex as the antigenic determinant.
1978
Animal models demonstrating respiratory responses to inhalant antigens.
1968
Evaluation of severe (anaphylactic) reactions
1978
Mould counts and exacerbations of allergic bronchopulmonary aspergillosis
1983
Serum IgE and IgG antibody activity against Aspergillus fumigatus as a diagnostic aid in allergic bronchopulmonary aspergillosis.
1978
Farmer's lung following inhalation of Aspergillus flavus growing in mouldy corn
1974
Bone studies in patients on prolonged systemic corticosteroid therapy for asthma
1982